Sangamo Therapeutics Announces Third Quarter 2022 Conference Call and Webcast

Rhea-AI Summary

Sangamo Therapeutics (NASDAQ: SGMO) announced it will release its third quarter 2022 financial results on November 3, 2022, after market close. A conference call will follow at 4:30 p.m. ET to discuss the results and provide business updates. Participants can register for the call through a provided link and are encouraged to join 10 minutes early. A replay will be available post-call.

Sangamo focuses on developing genomic medicines through gene therapy, cell therapy, and genome engineering.

Positive

• Scheduled release of Q3 2022 financial results indicates active business operations.
• Public conference call will enhance transparency with investors.

Negative

• None.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its third quarter 2022 financial results after the market closes on Thursday, November 3, 2022.

The press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public. During the conference call, the company will review its financial results and provide business updates.

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

A replay will be available following the conference call, accessible under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com and connect with us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005056/en/

Investor & Media Inquiries

Louise Wilkie

ir@sangamo.com

media@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

When will Sangamo Therapeutics release its Q3 2022 financial results?

Sangamo Therapeutics will release its Q3 2022 financial results on November 3, 2022.

What time is the Sangamo Therapeutics Q3 2022 conference call?

The conference call will take place at 4:30 p.m. ET.

How can I access the Sangamo Therapeutics conference call?

Participants can register and access the call via a link provided in their press release.

What does Sangamo Therapeutics focus on?

Sangamo Therapeutics focuses on genomic medicines, including gene therapy and genome engineering.